Overview:
The purpose of hemodynamic monitoring is maintenance of sufficient tissue perfusion. Conventional hemodynamic monitoring is based on invasive methods to measure pulmonary arterial, systemic, venous pressure and cardiac output. In cases of hypotension, which is the most common cause of hemodynamic instability, modern hemodynamic methods are used. Is assumed that the central venous pressure and central venous pressure (CVP) and pulmonary artery occlusion pressure (PAOP) are sufficient estimates of measuring systemic and pulmonary circulation respectively.
The suggested decision tree for the measurements are:
1. Take working diagnosis on the basis of relationship between PAOP and CVP and stroke volume or cardiac output.
2. Consider patient history
3. Consider conditions that may interfere with PAOP and CVP
4. Segregating right ventricular and left ventricular function by reciprocal variations of PAOP, SV and CVP
CVP is commonly used as the only parameter for hemodynamic monitoring. However, using CVP alone may not efficiently differentiate between volume changes and contractility. Other new techniques such as electrocardiography, volume-based monitoring system and transesophageal Doppler are now being increasingly adopted.
Over the coming years, the demand for hemodynamic mentoring is expected to gradually increase due to technological evolution in hemodynamic monitoring systems, rise in prevalence of cardiovascular diseases, hypertension and diabetes and rapid growth in aging population. Emerging countries such as India, China and parts of Middle East and Africa with their huge pool of hypertension and diabetes patients will serve as the potential markets for hemodynamic monitoring systems through the forecast period. Additionally, with the advent of non-invasive and minimally invasive solutions, the demand for invasive hemodynamic monitoring systems is anticipated to reduce, thus restraining the market growth.
The global hemodynamic monitoring systems market is segmented on the following bases:
1. Product Type
a. Invasive Hemodynamic Monitoring Systems
b. Minimally Invasive Hemodynamic Monitoring Systems
c. Non-Invasive Hemodynamic Monitoring Systems
2. Components Type
a. Monitoring Systems
b. Consumables
3. End-Users
a. Hospitals
b. Ambulatory Centers
c. Others
4. Geography
a. North America
i. US
ii. Canada
b. Europe
i. UK
ii. Germany
iii. Rest of Europe
c. Asia-Pacific
i. Japan
ii. China
iii. Rest of APAC
d. Latin America
e. Middle East and Africa
Key players identified for healthcare analytical testing market include but are not limited to:
Edwards Lifesciences Corporation , Osypka Medical GmbH, PULSION Medical Systems SE, Cheetah Medical, Inc., LiDCO Group plc, Tensys Medical, Inc., ICU Medical, Inc., and several others
This report offers:
- An overview of the global markets for hemodynamic monitoring systems
- Market trends assessment for the period 2014-2022, with historical information for 2014 & 2015, and projections through 2022, with respective CAGRS during 2016-2022
- Qualitative assessment tools such as market drivers, challenges and future prospects, major commercial events, etc.
- Market competition scrutiny tools such as market share analysis, attractive investment proposition, and Porter’s Five Forces model
- Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics
- A general overview of the industry structure
- Company profiles highlighting key information about the major players operating in the hemodynamic monitoring systems market
